Today announced three podium presentations and seven poster presentations during the American Academy of Ophthalmology (AAO) annual meeting, which will take place in San Francisco Nov. 3-6. Three podium presentations will feature an evaluation of the use of IC-8 Apthera intraocular lens (IOL) in patients with complex cases as well as an analysis of data on the unique Antibiotic Resistance Monitoring in Ocular MicRooganisms (ARMOR) surveillance study, which evaluates trends in antibiotic resistance among common ocular bacterial pathogens across the United States. Bausch + Lomb Corporation shares T.BLCO are trading unchanged at $22.50.